EE9900272A - Uudsed IFN-retseptoriga 1 seonduvad valgud, neid kodeeriv DNA ja interferoonidele suunatud raku vastuse moduleerimise meetodid - Google Patents

Uudsed IFN-retseptoriga 1 seonduvad valgud, neid kodeeriv DNA ja interferoonidele suunatud raku vastuse moduleerimise meetodid

Info

Publication number
EE9900272A
EE9900272A EEP199900272A EEP9900272A EE9900272A EE 9900272 A EE9900272 A EE 9900272A EE P199900272 A EEP199900272 A EE P199900272A EE P9900272 A EEP9900272 A EE P9900272A EE 9900272 A EE9900272 A EE 9900272A
Authority
EE
Estonia
Prior art keywords
cellular response
dna encoding
interferons
modulation
binding proteins
Prior art date
Application number
EEP199900272A
Other languages
English (en)
Inventor
Revel Michel
Abramovitch Carolina
Chebath Judith
Original Assignee
Yeda Research And Development Co. Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Research And Development Co. Ltd. filed Critical Yeda Research And Development Co. Ltd.
Publication of EE9900272A publication Critical patent/EE9900272A/et
Publication of EE04819B1 publication Critical patent/EE04819B1/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1003—Transferases (2.) transferring one-carbon groups (2.1)
    • C12N9/1007—Methyltransferases (general) (2.1.1.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EEP199900272A 1997-01-15 1998-01-15 Rekombinantne DNA molekul ja ekspressioonivektorit sisaldav peremeesrakk EE04819B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3563697P 1997-01-15 1997-01-15
PCT/US1998/000671 WO1998031796A1 (en) 1997-01-15 1998-01-15 Novel ifn receptor 1 binding proteins, dna encoding them, and methods of modulating cellular response to interferons

Publications (2)

Publication Number Publication Date
EE9900272A true EE9900272A (et) 2000-02-15
EE04819B1 EE04819B1 (et) 2007-04-16

Family

ID=21883894

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900272A EE04819B1 (et) 1997-01-15 1998-01-15 Rekombinantne DNA molekul ja ekspressioonivektorit sisaldav peremeesrakk

Country Status (20)

Country Link
US (1) US7264945B2 (et)
EP (1) EP1019500B1 (et)
JP (1) JP4614473B2 (et)
KR (2) KR100591988B1 (et)
CN (1) CN1212398C (et)
AT (1) ATE342972T1 (et)
AU (1) AU731206C (et)
BG (1) BG64829B1 (et)
BR (1) BR9806755A (et)
CA (1) CA2276111A1 (et)
CZ (1) CZ299096B6 (et)
DE (1) DE69836226T2 (et)
DK (1) DK1019500T3 (et)
EA (1) EA003250B1 (et)
EE (1) EE04819B1 (et)
ES (1) ES2275297T3 (et)
IL (2) IL130960A0 (et)
NO (1) NO326104B1 (et)
UA (1) UA75560C2 (et)
WO (1) WO1998031796A1 (et)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020119129A1 (en) * 1997-01-15 2002-08-29 Yeda Research And Development Co. Ltd. Novel IFN receptor 1 binding proteins, DNA encoding them, and methods of modulating cellular response to interferons
CA2471385A1 (en) * 2001-12-27 2003-07-10 Takeda Chemical Industries, Ltd. Preventives/remedies for cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4220759A1 (de) * 1992-06-24 1994-01-05 Inst Genbiologische Forschung DNA-Sequenzen für Oligosaccharid-Transporter, Plasmide, Bakterien und Pflanzen enthaltend einen Transporter sowie Verfahren zur Herstellung und Transformation von Hefestämmen zur Identifikation des Transporteers
IL107378A (en) * 1993-10-24 2005-05-17 Yeda Res & Dev SOLUBLE INTERFERON alpha-RECEPTOR, ITS PREPARATION AND USE
US6242587B1 (en) * 1996-10-02 2001-06-05 The University Of North Carolina At Chapel Hill DNA molecules encoding a calcium-integrin binding protein

Also Published As

Publication number Publication date
NO326104B1 (no) 2008-09-22
WO1998031796A1 (en) 1998-07-23
ATE342972T1 (de) 2006-11-15
CZ247199A3 (cs) 2000-01-12
AU731206B2 (en) 2001-03-29
IL130960A0 (en) 2001-01-28
EP1019500A4 (en) 2004-04-07
CZ299096B6 (cs) 2008-04-23
BG103627A (en) 2000-04-28
EP1019500B1 (en) 2006-10-18
US20030176678A1 (en) 2003-09-18
DE69836226D1 (de) 2006-11-30
AU731206C (en) 2002-05-16
DK1019500T3 (da) 2007-02-19
NO993412L (no) 1999-07-09
UA75560C2 (en) 2006-05-15
KR20050046779A (ko) 2005-05-18
IL130960A (en) 2008-03-20
EA199900663A1 (ru) 2000-02-28
ES2275297T3 (es) 2007-06-01
JP4614473B2 (ja) 2011-01-19
NO993412D0 (no) 1999-07-09
BG64829B1 (bg) 2006-05-31
KR100799828B1 (ko) 2008-01-31
BR9806755A (pt) 2000-03-14
CN1212398C (zh) 2005-07-27
KR20000070181A (ko) 2000-11-25
DE69836226T2 (de) 2007-02-01
EE04819B1 (et) 2007-04-16
CN1243544A (zh) 2000-02-02
CA2276111A1 (en) 1998-07-23
JP2001508306A (ja) 2001-06-26
KR100591988B1 (ko) 2006-06-21
EA003250B1 (ru) 2003-02-27
EP1019500A2 (en) 2000-07-19
US7264945B2 (en) 2007-09-04
WO1998031796A8 (en) 1999-05-20
AU5824098A (en) 1998-08-07

Similar Documents

Publication Publication Date Title
EE03271B1 (et) Inimesele kohandatud antikehad või nende siduvad proteiinid, nende valmistamismeetodid ja neid sisaldav farmatseutiline kompositsioon
UA27763C2 (uk) Рекомбінантна молекула днк, що кодує молекулу адгезії icam-3, молекула адгезії icam-3, антитіло, здатне зв'язуватись з такою молекулою, фармацевтична композиція
NZ502392A (en) Interleukin-18 binding proteins (IL-18BP) their preparation and use in pharmaceuticals
ATE544776T1 (de) Chimäre dna-bindeproteine
DK1427750T3 (da) Modificerede transferrin-fusionsproteiner
FI962247L (fi) Uudet apoptoosia muuntavat proteiinit, niitä koodaava DNA ja näiden käyttömenetelmät
TR200000654T2 (tr) KAY-Yeni bir bağışıklık sistemi proteini.
NO20000934D0 (no) Adipocyttspesifikke proteinhomologer
DE69834643D1 (de) Adipozyten-spezifische protein homologe
DE69434384D1 (de) Metalkomplexbildner
FI972170A7 (fi) Peptidejä, jotka kykenevät sitoutumaan GAP-proteiinin SH3-domeeniin, n äitä peptidejä koodittavia nukleotidisekvenssejä, niiden valmistus ja käyttö
DE69823225D1 (de) Fusionsproteine, bestehend aus proteinaseinhibitoren
NO995062L (no) <Beta>-anyloidpeptid-bindende proteiner og polynuldeotider som koder for samme
NO922421L (no) Collagenbindende protein, samt fremstilling derav
ATE452650T1 (de) Transferrin-fusionsproteinbibliotheken
EP1019500A4 (en) NEW IFN RECEPTOR 1 BINDING PROTEINS, ENCODING DNA AND METHOD FOR REGULATING THE CELLULAR RESPONSE TO INTERFERON
FI943218A7 (fi) Kaseinomakropeptidin peptidit, mainittujen peptidien vasta-aineet ja k äytöt
ATA41389A (de) Neue endotoxin-proteine aus bacillus thuringiensis
FI950516A0 (fi) Interferoni-alfa/beta-sitojaproteiini, sen valmistus ja käyttö
FI971872A0 (fi) Proteiinikoostumus ja sen valmistus ja käyttö sekä sitä sisältävät valmisteet ja näiden valmistus
DK270386A (da) Monoklonalt antistof til humant protein c, dets fremstilling og anvendelse
SI1019500T1 (sl) Proteini, ki vezejo receptor 1 za ifn, dna, ki jih kodira, in postopki za regulacijo celicnega odziva na interferone
RU94026276A (ru) Рецепторы интерлейкина-12 и антител
DK222390D0 (da) Heparin-bindende proteiner, dna'er, der koder for saadanne proteiner, fremgangsmaade til fremstilling af proteinerne same farmaceutiske praeparater indeholdende disse
TH30275A (th) โปรตีนดัดแปลง

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231